BioCardia, Inc.

BCDA Healthcare Biotechnology

BioCardia, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $477,000.00, up 722.4% from fiscal 2024. In the quarter to June 2026, EPS grew 67.5% and free cash flow fell 5.15%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

0.92 0.02 −2.13%
Market cap
$14.2M
P/E
0.0×
Fwd P/E
−1.7×
Dividend yield
—
F-score
4/9
Altman Z
−74.83
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
21.35 12.69 5.36 5.59 21.41 12.87 7.36 1.10 2.37 2.50
Receivables
0.07 0.10 0.27 0.15 0.85 0.15 0.20 0.06 — 0.02
Inventory
0.14 0.19 0.14 0.00 — — — — — —
Total current assets
21.92 13.32 6.22 6.38 22.66 13.48 7.86 1.46 2.62 2.73
Property, Plant, Equpment (Net)
0.11 0.17 0.15 0.18 0.15 0.18 0.17 0.09 0.03 0.02
Long-term assets (Other)
0.05 0.05 0.05 0.05 0.05 0.17 0.17 0.17 0.17 0.17
Total non-current assets
0.17 0.22 0.20 1.30 0.77 2.24 1.93 1.53 1.10 0.68
Total Assets
22.08 13.54 6.42 7.68 23.42 15.72 9.79 2.99 3.72 3.41
Accounts Payable
0.53 0.90 0.74 0.91 0.75 0.51 0.68 0.89 0.39 0.64
Accrued Expenses
0.85 1.26 1.81 2.56 2.21 2.12 2.25 2.39 1.55 1.35
Current Revenue (Deferred)
0.07 0.17 — — 0.68 0.85 0.34 — — —
Total current liabilities
1.44 2.33 2.55 4.00 4.25 3.71 3.59 3.61 2.32 2.43
Non-current Revenue (Deferred)
0.06 0.08 0.08 0.69 — — — — — —
Total non-current liabilities
0.06 0.08 0.08 1.31 — 1.63 1.32 0.98 0.57 0.09
Total liabilities
1.50 2.41 2.63 5.31 4.25 5.34 4.90 4.59 2.89 2.52
Additional Paid In Capital
80.69 83.54 90.15 (101.07) 135.23 139.06 145.48 150.57 160.95 169.23
Common Stock (Net)
0.04 0.04 0.01 0.01 0.02 0.02 0.02 0.00 0.01 0.01
Retained Earnings
(60.14) (72.45) (86.36) 103.43 (116.07) (128.70) (140.60) (152.17) (160.12) (168.35)
Common Equity (Total)
20.58 11.13 3.79 2.37 19.18 10.38 4.89 (1.60) 0.84 0.90
Shareholders Equity (Total)
20.58 11.13 3.79 2.37 19.18 10.38 4.89 (1.60) 0.84 0.90
Shareholders Equity and Liabilities (Total)
22.08 13.54 6.42 7.68 23.42 15.72 9.79 2.99 3.72 3.41
Shares (Common)
0.28 0.28 0.32 0.46 1.09 1.13 1.34 1.58 4.60 10.76
Shareholders Equity (Tangible)
20.58 11.13 3.79 2.37 19.18 10.38 4.89 (1.60) 0.84 0.90
Net Debt
(21.35) (12.69) (5.36) (5.58) (21.41) (12.87) (7.36) (1.10) (2.37) (2.50)
Total Debt
— — — 0.53 0.61 0.24 0.32 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates